Graig Suvannavejh Analyst PerformanceAnalyst at The Goldman Sachs GroupGraig Suvannavejh is a stock analyst at The Goldman Sachs Group focused in the medical sector, covering 27 publicly traded companies. Over the past year, Graig Suvannavejh has issued 67 stock ratings, including buy, hold, and sell recommendations. While full access to Graig Suvannavejh's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Graig Suvannavejh's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings83 Last 7 YearsBuy Recommendations82.26% 51 Buy RatingsCompanies Covered27 Unique Companies Ratings Distribution62RatingsDistribution of strong buy, buy, hold, and sell ratings by Graig Suvannavejh.RatingPercentageCount Strong Buy0.0%0 ratings Buy82.3%51 ratings Hold16.1%10 ratings Sell1.6%1 ratingsOut of 62 total stock ratings issued by Graig Suvannavejh at The Goldman Sachs Group, the majority (82.3%) have been Buy recommendations, followed by 16.1% Hold and 1.6% Sell.Best & Worst CallsBest Call0000.0%AMLXApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ALECJul 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ27 companiesGraig Suvannavejh, an analyst at The Goldman Sachs Group, currently covers 27 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical26 companies96.3%Manufacturing1 company3.7%Graig Suvannavejh of The Goldman Sachs Group specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE25 companies92.6%MED - DRUGS1 company3.7%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES1 company3.7% Graig Suvannavejh's Ratings History at The Goldman Sachs Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAXSMAxsome Therapeutics5/5/2026Boost Price Target$224.03$310.00Outperform$0.0000.00% ROIAMLXAmylyx Pharmaceuticals4/28/2026Boost Price Target$16.88$21.00Outperform$0.0000.00% ROIAPLSApellis Pharmaceuticals4/2/2026Boost Price Target$40.39$41.00Neutral$0.0000.00% ROIIMMXImmix Biopharma3/30/2026Boost Price Target$8.27$15.00Outperform$0.0000.00% ROIINSMInsmed3/25/2026Boost Price Target$145.11$206.00Outperform$0.0000.00% ROIAPLSApellis Pharmaceuticals3/5/2026Boost Price Target$19.86$20.00Neutral$0.0000.00% ROIPVLAPalvella Therapeutics2/25/2026Boost Price Target$122.56$250.00Outperform$0.0000.00% ROIINSMInsmed2/24/2026Lower Price Target$159.03$204.00Outperform$0.0000.00% ROIAXSMAxsome Therapeutics2/19/2026Set Price Target$184.74$230.00$0.0000.00% ROIVSTMVerastem2/19/2026Set Price Target$5.78$18.00$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. INSMInsmed2/19/2026Set Price Target$151.11$211.00$0.0000.00% ROIIMTXImmatics2/19/2026Set Price Target$9.95$25.00$0.0000.00% ROIHRMYHarmony Biosciences2/19/2026Set Price Target$35.23$50.00$0.0000.00% ROIBLTEBelite Bio2/19/2026Set Price Target$173.91$223.00$0.0000.00% ROILONAAthira Pharma2/19/2026Upgrade$4.76$10.00Outperform$0.0000.00% ROIIMMXImmix Biopharma2/9/2026Initiated Coverage$6.74$14.00Outperform$0.0000.00% ROIIMMXImmix Biopharma2/9/2026Initiated Coverage$6.42$14.00Outperform$0.0000.00% ROICRVSCorvus Pharmaceuticals1/29/2026Set Price Target$20.54$30.00$0.0000.00% ROIERASErasca1/27/2026Initiated Coverage$9.95$16.00Outperform$0.0000.00% ROIPVLAPalvella Therapeutics1/7/2026Initiated Coverage$90.43$205.00Outperform$0.0000.00% ROINMRANeumora Therapeutics1/5/2026Set Price Target$1.69$6.00$0.0000.00% ROIAXSMAxsome Therapeutics12/31/2025Set Price Target$183.34$217.00$0.0000.00% ROIINSMInsmed12/18/2025Set Price Target$165.73$212.00$0.0000.00% ROIERASErasca12/9/2025Boost Price Target$3.34$5.00Outperform$0.0000.00% ROITERNTerns Pharmaceuticals12/9/2025Boost Price Target$40.23$54.00Outperform$0.0000.00% ROIHALOHalozyme Therapeutics12/4/2025Reiterated Rating$64.66$56.00Sell$0.0000.00% ROIBLTEBelite Bio12/2/2025Set Price Target$154.02$194.00Outperform$0.0000.00% ROIBLTEBelite Bio12/2/2025Upgrade$150.84$194.00Outperform$0.0000.00% ROIHRMYHarmony Biosciences12/1/2025Boost Price Target$35.26$46.00Outperform$0.0000.00% ROIINSMInsmed12/1/2025Boost Price Target$206.43$256.00Outperform$0.0000.00% ROITERNTerns Pharmaceuticals11/28/2025Set Price Target$28.75$33.00$0.0000.00% ROITARSTarsus Pharmaceuticals11/20/2025Initiated Coverage$77.11$100.00Outperform$0.0000.00% ROIBLTEBelite Bio11/20/2025Initiated Coverage$120.36$105.00Neutral$0.0000.00% ROIIMTXImmatics11/19/2025Boost Price Target$10.33$23.00Outperform$0.0000.00% ROIHALOHalozyme Therapeutics11/18/2025Boost Price Target$70.20$56.00Neutral$0.0000.00% ROITERNTerns Pharmaceuticals11/13/2025Boost Price Target$20.30$33.00Outperform$0.0000.00% ROIIDYAIDEAYA Biosciences11/11/2025Boost Price Target$30.89$46.00Outperform$0.0000.00% ROIAXSMAxsome Therapeutics11/6/2025Boost Price Target$138.17$202.00Outperform$0.0000.00% ROIHRMYHarmony Biosciences11/6/2025Boost Price Target$30.66$39.00Outperform$0.0000.00% ROITERNTerns Pharmaceuticals11/4/2025Boost Price Target$18.19$32.00Outperform$0.0000.00% ROIAPLSApellis Pharmaceuticals11/3/2025Lower Price Target$21.47$19.00Neutral$0.0000.00% ROIVSTMVerastem10/29/2025Set Price Target$8.76$15.00$0.0000.00% ROIINSMInsmed10/29/2025Set Price Target$166.29$196.00$0.0000.00% ROIIMTXImmatics10/29/2025Set Price Target$10.36$19.00$0.0000.00% ROIHRMYHarmony Biosciences10/29/2025Set Price Target$28.97$36.00$0.0000.00% ROITERNTerns Pharmaceuticals10/22/2025Set Price Target$7.50$9.00$0.0000.00% ROIALECAlector10/22/2025Set Price Target$3.21$1.50Neutral$0.0000.00% ROIALECAlector10/22/2025Downgrade$1.61$1.50Neutral$0.0000.00% ROIVSTMVerastem10/21/2025Set Price Target$8.05$14.00$0.0000.00% ROIEYPTEyepoint Pharmaceuticals10/20/2025Set Price Target$11.63$28.00$0.0000.00% ROIKALAKALA BIO9/30/2025Set Price Target$1.77$1.50$0.0000.00% ROIKALAKALA BIO9/30/2025Downgrade$1.82Neutral$0.0000.00% ROIHRMYHarmony Biosciences9/25/2025Lower Price Target$26.48$35.00Outperform$0.0000.00% ROIATHAAthira Pharma9/19/2025Set Price Target$3.91$4.00$0.0000.00% ROIIDYAIDEAYA Biosciences9/12/2025Boost Price Target$25.12$44.00Outperform$0.0000.00% ROIKALAKALA BIO9/8/2025Initiated Coverage$14.55$30.00Outperform$0.0000.00% ROIINSMInsmed8/13/2025Boost Price Target$122.00$165.00Outperform$0.0000.00% ROIALECAlector7/28/2025Upgrade$1.76$3.50Outperform$0.0000.00% ROINMRANeumora Therapeutics7/16/2025Boost Price Target$1.45$5.00Outperform$0.0000.00% ROIADAPAdaptimmune Therapeutics6/26/2025Downgrade$0.25$0.50Neutral$0.0000.00% ROIADVMAdverum Biotechnologies6/26/2025Lower Price Target$2.47$12.00Outperform$0.0000.00% ROIIMRXImmuneering6/18/2025Boost Price Target$2.18$10.00Outperform$0.0000.00% ROIINSMInsmed6/11/2025Boost Price Target$98.09$110.00Outperform$0.0000.00% ROICRVSCorvus Pharmaceuticals5/20/2025Set Price Target$3.57$11.00Outperform$0.0000.00% ROIEYPTEyepoint Pharmaceuticals5/16/2025Lower Price Target$5.93$26.00Outperform$0.0000.00% ROIHRMYHarmony Biosciences5/15/2025Boost Price Target$33.87$48.00Outperform$0.0000.00% ROIAPLSApellis Pharmaceuticals5/14/2025Lower Price Target$16.86$20.00Neutral$0.0000.00% ROIAMLXAmylyx Pharmaceuticals4/7/2025Upgrade$3.43$7.00Outperform$00.0000.00% ROIAXSMAxsome Therapeutics3/27/2025Boost Price Target$119.16$216.00Outperform$000.0000.00% ROIHRMYHarmony Biosciences3/18/2025Boost Price Target$34.32$44.00Outperform$00.0000.00% ROIAXSMAxsome Therapeutics2/26/2025Boost Price Target$129.67$212.00Outperform$000.0000.00% ROIHRMYHarmony Biosciences2/20/2025Lower Price Target$34.92$42.00Outperform$00.0000.00% ROIAXSMAxsome Therapeutics2/11/2025Boost Price Target$127.08$195.00Outperform$000.0000.00% ROIAXSMAxsome Therapeutics2/3/2025Boost Price Target$107.14$137.00Outperform$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James FinancialStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
